PolitiFact Examines Trade Deals’ Potential Impacts On Indian Generic Drug Manufacturers, Access To Medicines

PolitiFact: Do trade deals threaten India as low-cost HIV drug maker?
“…Doctors Without Borders said that trade deals threaten the capacity of Indian generic drug makers to produce the next round of HIV drugs. We found that trade negotiations, whether part of large regional trade agreements or unilateral discussions between the United States and India, have language that work against India generic drug makers. … Our experts disagreed on whether this would reduce access to critical drugs. The trade deals do no favors for India’s generic drug makers. With a caveat about future access to drugs, we rate this claim Mostly True” (Greenberg, 8/3).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.